Dr. Reddy’s Laboratories Listed in the First Sector-Neutral Bloomberg Gender-Equality Index

Dr. Reddy’s Laboratories Ltd has been featured in the inaugural 2018 Bloomberg Gender-Equality Index (“GEI”). Dr. Reddy’s is the only pharmaceutical company globally and the only Indian company to be recognized for its efforts in creating a work environment that supports gender equality. The 2018 GEI comprises of 104 companies headquartered in 24 countries from across sectors - communications, consumer staples, energy, financials, materials, pharmaceuticals and technology. The index measures gender equality across internal company statistics, employee policies, external community support and engagement, and gender-conscious product offerings. Satish Reddy, Chairman, Dr. Reddy’s Laboratories said, “At Dr. Reddy’s, we strongly believe in a gender diverse workplace and have designed our people practices to ensure safe, friendly and conducive environment to all our women employees. The GRI listing is another validation of our policies that attract, retain and develop women talent at Dr. Reddy’s.” The Bloomberg Gender-Equality Index (GEI) is a Bloomberg- created reference index that measures gender equality. It rewards firms for disclosure as well as to showcase firms that have made strong commitments to gender equality.